|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4704 | |
| A61P 25/00 | |||
| A61P 25/16 | |||
| A61P 25/18 | |||
| A61P 25/22 | |||
| A61P 25/24 | |||
| A61P 25/28 | |||
| A61K 31/138 | |||
| A61K 31/428 |
| (11) | Patento numeris | 3064206 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16160522.5 |
| Europos patento paraiškos padavimo data | 2010-08-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 273920 P | 2009-08-10 | US |
| (72) |
HAYARDENY, Liat, IL
|
| (73) |
Active Biotech AB,
Box 724, 220 07 Lund,
SE
|
| (54) | TREATMENT OF HUNTINGTON`S DISEASE USING LAQUINIMOD |
| TREATMENT OF HUNTINGTON`S DISEASE USING LAQUINIMOD |